pharmaceuticals

pharmaceuticals Articles

On Wednesday, Johnson & Johnson announced that a subsidiary had entered a definitive agreement to acquire a robotic technology firm focused on lung cancer.
Teva released mixed fourth-quarter financial results before the markets opened on Wednesday and its shares pulled back.
The January 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Here, 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and U.S. Food and Drug Administration (FDA) updates in February and March.
Merck released better-than-expected fourth-quarter financial results after the markets closed on Thursday.
Merck is scheduled to release its fourth-quarter before the markets open on Friday, and analysts are looking for solid top and bottom line growth.
The biotech team at SunTrust feel that it would not be a major surprise to see these six top companies post quarterly results that beat top-line Wall Street expectations.
More and more branded drugs seem to be facing generic competition. The impact might not be so positive for Big Pharma giants, but this can be a serious victory for consumers and patients who are in...
There is great opportunity in healthcare. There is also quite a lot of risk. Politicians and consumers alike want lower drug prices. Patients want the best of the best options for devices,...
Pfizer released better-than-expected fourth-quarter financial results and guidance before the markets opened on Tuesday.
Pfizer is scheduled to release its fourth-quarter financial results before the markets open on Tuesday. Consensus estimates call for modest year-over-year growth.
The January 15 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
AbbVie shares retreated after it released disappointing fourth-quarter financial results before the markets opened on Friday.
Bristol-Myers Squibb reported better-than-expected quarterly results before the markets opened on Thursday.
Johnson & Johnson released better-than-expected fourth-quarter financial results before the markets opened on Tuesday.